Sofie Wilgenhof
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 58
- Cancer Immunotherapy and Biomarkers 33
- CAR-T cell therapy research 25
- Cutaneous Melanoma Detection and Management 13
- Immunology 37
- Immunotherapy and Immune Responses 33
- Co-authors
- Bart Neyns (44 shared papers)Kris Thielemans (23 shared papers)Jurgen Corthals (21 shared papers)John B.A.G. Haanen (22 shared papers)Carlo Heirman (20 shared papers)Maartje W. Rohaan (6 shared papers)Aude Bonehill (17 shared papers)An M. T. Van Nuffel (13 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (13 papers)Melanoma Research (8 papers)Cancer Immunology Immunotherapy (4 papers)European Journal of Cancer (3 papers)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Sofie Wilgenhof
84 papers receiving 2.8k citations
Sofie Wilgenhof's Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology 1.4k
- Oncology 1.6k
- Molecular Biology 1.0k
- Cancer Research 194
- Pulmonary and Respiratory Medicine 354
Countries citing papers authored by Sofie Wilgenhof
This map shows the geographic impact of Sofie Wilgenhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Wilgenhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Wilgenhof more than expected).
Fields of papers citing papers by Sofie Wilgenhof
This network shows the impact of papers produced by Sofie Wilgenhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Wilgenhof. The network helps show where Sofie Wilgenhof may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofie Wilgenhof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 305 | |
| 2 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors Hit paper breakdown → | 2021 | 271 |
| 3 | 2016 | 254 | |
| 4 | 2013 | 179 | |
| 5 | 2011 | 150 | |
| 6 | 2011 | 127 | |
| 7 | 2020 | 122 | |
| 8 | 2016 | 120 | |
| 9 | 2012 | 95 | |
| 10 | 2012 | 85 | |
| 11 | 2014 | 79 | |
| 12 | 2013 | 71 | |
| 13 | Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor. | 2012 | 71 |
| 14 | 2013 | 67 | |
| 15 | 2014 | 66 | |
| 16 | 2011 | 59 | |
| 17 | 2012 | 45 | |
| 18 | 2012 | 43 | |
| 19 | 2015 | 36 | |
| 20 | 2014 | 34 |
About Sofie Wilgenhof
Sofie Wilgenhof is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 87 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (33 papers), Immunotherapy and Immune Responses (33 papers), CAR-T cell therapy research (25 papers), Melanoma and MAPK Pathways (19 papers), Cutaneous Melanoma Detection and Management (13 papers), RNA Interference and Gene Delivery (7 papers), vaccines and immunoinformatics approaches (7 papers) and Renal cell carcinoma treatment (6 papers). The work is most often cited by research in Immunology (1.4k citations), Oncology (1.6k citations), Molecular Biology (1.0k citations), Cancer Research (194 citations) and Pulmonary and Respiratory Medicine (354 citations). Sofie Wilgenhof has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Bart Neyns, Kris Thielemans, Jurgen Corthals, John B.A.G. Haanen, Carlo Heirman, Maartje W. Rohaan, Aude Bonehill, An M. T. Van Nuffel, Daphné Benteyn and Nicolas van Baren. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Melanoma Research, Cancer Immunology Immunotherapy and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.